12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CompleoTRT: Preliminary Phase III data

Preliminary data from 139 evaluable patients in an open-label, U.S. Phase III trial showed that twice- and thrice-daily CompleoTRT produced average serum testosterone levels within the normal range in...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >